Komiyama Shinichi

コミヤマシンイチ | Komiyama Shinichi

Affiliation and department：
Job title： Associate Professor
Homepage URL (1)： https://www.lab.toho-u.ac.jp/med/omori/gyne_oncology/

Research field (1)： Obstetrics and gynecology

Research keywords (21)： anti VEGF , chemotherapy , bevacizumab , 網羅的解析 , 臨床試験 , Gynecologic surgery , 卵巣明細胞腺癌 , 術前化学療法 , 原発性腹膜癌 , 臨床病理学的検討 , 卵巣癌 , RMG-1 , 腫瘍減量術 , 分子標的治療 , 癌関連ガラクトース転移酵素 , 腹膜癌 , 予後因子 , 多施設共同研究 , β1,4-ガラクトース転移酵素 , TGFβ1 , 抗腫瘍効果

Research theme for competitive and other funds (5)：

2013 - 2017 Molecular pathological study of primary peritoneal cancer
2009 - 2010 本邦における原発性腹膜癌に関する多施設共同研究
2006 - 2007 A new strategy of molecular targeting therapy for ovarian clear cell adenocinoma using transforming growth factor-betal(TGFβ1)
1998 - 1998 卵巣明細胞腺癌と子宮内膜症の共存に関する基礎的検討
1996 - 1996 癌化に伴って変化する糖転移酵素の放出機序解明の試み-卵巣癌細胞の産生するガラクトース転移酵素について-

Papers (101)：

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Eiji Kondo, Junzo Hamanishi, Kenichi Harano, Kosei Hasegawa, Takeshi Hirasawa, Kensuke Hori, et al. Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study. Journal of gynecologic oncology. 2024. 35. 5. e114
Tomoko Sakamoto Taniguchi, Shinichi Komiyama, Masaru Nagashima, Mineto Morita. Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience. European Journal of Gynaecological Oncology. 2021. 42. 4. 752-752
Masaru Nagashima, Shinichi Komiyama, Takayuki Yoshida, Yuria Kimura, Sota Sadamoto, Arisa Saito, Takayuki Rikitake, Masafumi Katakura, Tomoko Taniguchi, Mineto Morita. Intravenous leiomyomatosis successfully treated by multidisciplinary treatment including GnRH antagonist Relugolix. Medicine: Case Reports and Study Protocols. 2021. 2. 2
Tadahiro Shoji, Takayuki Enomoto, Masakazu Abe, Aikou Okamoto, Takayuki Nagasawa, Tetsuro Oishi, Satoru Nagase, Masahiko Mori, Yuki Inokuchi, Shoji Kamiura, et al. Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023. Cancer Science. 2021
齋藤有沙, 谷口智子, 木村ゆりあ, 吉田隆之, 米山雅人, 片倉雅文, 長島克, 土屋雄彦, 小宮山慎一, 森田峰人. 子宮体癌脳転移の2例. 日本婦人科腫瘍学会雑誌. 2021. 39. 1. 379-379

ｍore...

MISC (146)：

中村俊昭, 田畑務, 柳田聡, 近藤英司, 濱西潤三, 原野謙一, 長谷川幸清, 平澤猛, 堀謙輔, 小宮山慎一, et al. 前治療歴を有する高悪性度漿液性卵巣癌患者を対象としたニラパリブの国内第II相臨床試験の最終結果(The Final Results of a Japanese Phase 2 Study of Niraparib in Heavily Pretreated, HRd High-grade Serous Ovarian Cancer Patients). 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 193-193
A case of squamous cell carcinoma of the cervix with adult granulosa cell tumor of the ovary. 2017. 66. 1. 144-148
Komiyama, S., Manrai, M., Takahashi, R., Takeya, C. Safe dissection of high paraaortic lymph nodes superior to the renal vein in ovarian, primary peritoneal, or fallopian tube cancer by the “Komiyama's maneuver”, a modification of Kocher's maneuver. Gynecologic Oncology. 2017. 145. 2. 407-408
小宮山慎一. 卵巣がん・卵管がん・原発性腹膜がんのFIGO進行期分類2014の要点と臨床的意義 (今月の臨床婦人科悪性腫瘍規約改訂のポイントと対応 : 「何が」「なぜ」「どのように」変わったのか) -- (卵巣腫瘍). 臨床婦人科産科. 2016. 70. 8. 741-747
A case of treatment-resistant vaginal intraepithelial neoplasia. 2016. 65. 2. 247-250

ｍore...

Lectures and oral presentations (2)：

がん臨床試験-基礎編- 臨床試験の論文を読んでみよう
(日本臨床試験研究会教育セミナー「がん臨床試験セミナー」 2013)
婦人科がん治療における最近の話題 -制吐療法を中心に-
(群馬婦人科腫瘍支持療法セミナー 2013)

Work history (5)：

2018/07 - 現在 Faculty of Medicine Faculty of Medicine School of Medicine (Omori)
2012 - 現在 Toho University Faculty of Medicine
2012/04 - 2018/06 Faculty of Medicine Faculty of Medicine School of Medicine (Ohashi)
2005 - 2011 藤田保健衛生大学医学部講師
1996 - 2004 Keio University School of Medicine

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page